-
公开(公告)号:US08598216B1
公开(公告)日:2013-12-03
申请号:US13328043
申请日:2011-12-16
申请人: Maurizio Acquasaliente , Didier Houllemare , Geoff Zhang , Pulla Singam , John Morris , Kennan Marsh , Martin Babcock , John Pavlina , Yi Shi , Yuchuan Gong
发明人: Maurizio Acquasaliente , Didier Houllemare , Geoff Zhang , Pulla Singam , John Morris , Kennan Marsh , Martin Babcock , John Pavlina , Yi Shi , Yuchuan Gong
IPC分类号: A61K31/426 , A61K31/41
CPC分类号: C07D277/18
摘要: The invention relates to ritonavir bis-hydrochloride, processes for the preparation of the ritonavir bis-hydrochloride, pharmaceutical compositions containing the ritonavir bis-hydrochloride and made from it, and methods of using the ritonavir bis-hydrochloride to inhibit HIV protease or enhance the pharmacokinetics of compounds which are metabolized by cytochrome P450 3A4.
摘要翻译: 本发明涉及利托那韦双盐酸盐,制备利托那韦双盐酸盐的方法,含有利托那韦双盐酸盐并由其制备的药物组合物,以及使用利托那韦双盐酸盐抑制HIV蛋白酶或增强药代动力学的方法 的化合物,其被细胞色素P450 3A4代谢。